The Rat Model in the Comparative Evaluation of Anthracyclines Cardiotoxicity
Open Access
- 1 December 1989
- journal article
- research article
- Published by SAGE Publications in Tumori Journal
- Vol. 75 (6) , 533-536
- https://doi.org/10.1177/030089168907500603
Abstract
In the present investigation, the cardiotoxic effects of three anthracycline analogs (doxorubicin, 4′-epi-doxorubicin and 4′-deoxy-doxorubicin) were compared. For this purpose, 9.0 mg/kg of doxorubicin, divided into three closely spaced sub-doses, were injected intravenously in rats. The two derivatives were administered according to the same time schedule and their doses were chosen on the basis of the clinically adopted ratio, doxorubicin : 4′-epidoxorubicin : 4′-deoxy-doxorubicin = 1:1: 0.5. The degree of cardiomyopathy induced by the three anthracyclines was evaluated by ECG changes and morphological alterations. Doxorubicin was found to produce a significant degree of cardiotoxicity, thus confirming the validity of the experimental model adopted. Both 4′-substituted derivatives proved to be less cardiotoxic than the parent compound, although not completely devoid of this side effect.This publication has 17 references indexed in Scilit:
- Anthracycline analogs The past, present, and futureCancer Chemotherapy and Pharmacology, 1986
- New anthracycline analogs in advanced breast cancerEuropean Journal of Cancer and Clinical Oncology, 1986
- Relationship between Doxorubicin-Induced Ecg Changes and Myocardial Alterations in RatsTumori Journal, 1986
- Comparison of Lipid Peroxidation and Myocardial Damage Induced by Adriamycin and 4′-Epiadriamycin in MiceTumori Journal, 1985
- Absence of generation of oxygen-containing free radicals with 4′-deoxydoxorubicin, a non-cardiotoxic anthracycline drugBiochemical and Biophysical Research Communications, 1984
- Pharmacokinetics of 4′-epi-doxorubicin in manInvestigational New Drugs, 1983
- Cardiomyopathy of Doxorubicin in Experimental Animals. Factors Affecting the Severity, Distribution and Evolution of Myocardial LesionsTumori Journal, 1981
- The Anthracycline Antineoplastic DrugsNew England Journal of Medicine, 1981
- Fluorescence assays and pharmacokinetic studies of 4′-deoxydoxorubicin and doxorubicin in organs of mice bearing solid tumorsCancer Chemotherapy and Pharmacology, 1981
- Inhibition of coenzyme Q10-enzymes, succinoxidase and NADH-oxidase, by adriamycin and other quinones having antitumor activityBiochemical and Biophysical Research Communications, 1974